Immunopathological inflammation in patients with psoriasis is effectively reduced by bimekizumab treatment targeting simultaneously IL-17A and IL-17F
-
Published:2023-03-28
Issue:1
Volume:17
Page:16-19
-
ISSN:1802-2960
-
Container-title:Dermatologie pro praxi
-
language:
-
Short-container-title:Dermatol. praxi